array:19 [
  "pii" => "X021169950402967X"
  "issn" => "02116995"
  "estado" => "S300"
  "fechaPublicacion" => "2004-02-01"
  "documento" => "article"
  "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
  "subdocumento" => "fla"
  "cita" => "Nefrologia. 2004;24 Supl 1:28"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 2123
    "formatos" => array:3 [
      "EPUB" => 257
      "HTML" => 1444
      "PDF" => 422
    ]
  ]
  "itemSiguiente" => array:15 [
    "pii" => "X0211699504029661"
    "issn" => "02116995"
    "estado" => "S300"
    "fechaPublicacion" => "2004-02-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2004;24 Supl 1:29-32"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 6811
      "formatos" => array:3 [
        "EPUB" => 271
        "HTML" => 5325
        "PDF" => 1215
      ]
    ]
    "es" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "Factores determinantes de la presión del pulso en la enfermedad renal crónica"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "29"
          "paginaFinal" => "32"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "J. LUÑO , F. J. GÓMEZ CAMPDERÁ , S. GARCÍA DE VINUESA , M. GOICOECHEA"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "J. LUÑO , F. J. GÓMEZ CAMPDERÁ , S. GARCÍA DE VINUESA , M. GOICOECHEA"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699504029661?idApp=UINPBA000064"
    "url" => "/02116995/00000024000000S1/v0_201502091335/X0211699504029661/v0_201502091335/es/main.assets"
  ]
  "itemAnterior" => array:15 [
    "pii" => "X0211699504029688"
    "issn" => "02116995"
    "estado" => "S300"
    "fechaPublicacion" => "2004-02-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2004;24 Supl 1:27"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 2029
      "formatos" => array:3 [
        "EPUB" => 225
        "HTML" => 1376
        "PDF" => 428
      ]
    ]
    "en" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "Efecto del bloqueo del sistema renina angiotensina sobre la progresión de la nefropatía diabética"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:1 [
          "paginaInicial" => "27"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "S. SHAHINFAR"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "S. SHAHINFAR"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699504029688?idApp=UINPBA000064"
    "url" => "/02116995/00000024000000S1/v0_201502091335/X0211699504029688/v0_201502091335/en/main.assets"
  ]
  "en" => array:8 [
    "idiomaDefecto" => true
    "titulo" => "Progresión del sistema renina angiotensina, remisión y regresión de las nefropatías crónicas"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:1 [
        "paginaInicial" => "28"
      ]
    ]
    "autores" => array:1 [
      0 => array:2 [
        "autoresLista" => "G. REMUZZI"
        "autores" => array:1 [
          0 => array:1 [
            "nombre" => "G. REMUZZI"
          ]
        ]
      ]
    ]
    "textoCompleto" => "NEFROLOGÍA. Vol. XXIV. Número Extraordinario (I). 2004 Progresión del sistema renina angiotensina, remisión y regresión de las nefropatías crónicas G. Remuzzi, M.D. FRCP. Negri Bergamo Laboratories. Bergamo. Italy. The number of patients with chronic renal disease is increasing world-wide. Most of chronic nephropathies lack of a specific treatment and progress relentlessly toward ESRD. In the last two decades an enormous wealth of information have been gathered from animal and human studies that have shed light on the mechanisms of progression and indicated means to prevent it. The concept of renoprotection has emerged and is already growing into a combined approach to renal diseases. Pharmacological control of blood pressure and reduction of proteinuria have proven to be the most important measures to arrest progression. A multimodal protocol is emerging as the modern management for renal patients, which includes combination of several antihypertensive drugs lowering lipids, smoking cessation, tight glucose control for diabetics. A number of new compounds are under evaluation in animal studies, and hopefully will become soon part of the treatment strategy. With the available therapies, delay of dialysis initiation is an achievable goal today for many patients with chronic nephropathies, but it is only a limited result, being the perspective of less dialysis what is really needed. Remission of renal diseases and regression of renal structural damage of the kidney are the pre-requisite for such objective: there are initial experimental and clinical data that give support to the notion that it is possible. Less dialysis (and maybe no more, for some patients) remains an optimistic but not unfounded perspective for the years to come. Renal replacement therapy (RRT), either by hemodialysis, peritoneal dialysis, or renal transplantation, provides patients with end stage renal disease (ESRD) with a long survival, and in most cases with a good quality of life. In all rich countries every year new dialysis patients outnumber those who died, allowing the stock of patients on RRT to grow in parallel with costs. Providing adequate treatment to all patients is indeed extolling a significant proportion of the health care budget and is being considered with concern by those who have responsibility such as health providers and policy makers. Since the prospect of rationing dialysis and establishing priorities for treatment is out of question, we should take upon us the challenge to search strategies to prevent dialysis for as many patients as possible. Many years ago a Professor of Medicine in Manchester, Dr. Robert Platt, was the first to have the intuition that renal failure was the consequence of structural and functional adaptation to loss of kidney substance. He established the concept of renal failure «as an extremely efficient function by a renal remnant now too small for its task». For many years the nephrologists have spent all the efforts to avoid loss of nephrons, most often with little success, by attempting to cure renal diseases. In the early Eighties Dr. Barry Brenner changed completely the perspective, rather pointing the attention on the preservation of the function of remaining nephrons by blocking the progression due to nephron loss. A completely new era of Nephrology started from his seminal work. 28 "
    "pdfFichero" => "P7-E232-S132-A2978.pdf"
    "tienePdf" => true
  ]
  "idiomaDefecto" => "en"
  "url" => "/02116995/00000024000000S1/v0_201502091335/X021169950402967X/v0_201502091335/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "35393"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Artículos Originales"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/02116995/00000024000000S1/v0_201502091335/X021169950402967X/v0_201502091335/en/P7-E232-S132-A2978.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X021169950402967X?idApp=UINPBA000064"
]
Compartir
Información de la revista

Estadísticas

Siga este enlace para acceder al texto completo del artículo

Progresión del sistema renina angiotensina, remisión y regresión de las nefropatías crónicas
G. REMUZZI
Leído
5187
Veces
se ha leído el artículo
2056
Total PDF
3131
Total HTML
Compartir estadísticas
 array:19 [
  "pii" => "X021169950402967X"
  "issn" => "02116995"
  "estado" => "S300"
  "fechaPublicacion" => "2004-02-01"
  "documento" => "article"
  "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
  "subdocumento" => "fla"
  "cita" => "Nefrologia. 2004;24 Supl 1:28"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 2123
    "formatos" => array:3 [
      "EPUB" => 257
      "HTML" => 1444
      "PDF" => 422
    ]
  ]
  "itemSiguiente" => array:15 [
    "pii" => "X0211699504029661"
    "issn" => "02116995"
    "estado" => "S300"
    "fechaPublicacion" => "2004-02-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2004;24 Supl 1:29-32"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 6811
      "formatos" => array:3 [
        "EPUB" => 271
        "HTML" => 5325
        "PDF" => 1215
      ]
    ]
    "es" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "Factores determinantes de la presión del pulso en la enfermedad renal crónica"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "29"
          "paginaFinal" => "32"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "J. LUÑO , F. J. GÓMEZ CAMPDERÁ , S. GARCÍA DE VINUESA , M. GOICOECHEA"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "J. LUÑO , F. J. GÓMEZ CAMPDERÁ , S. GARCÍA DE VINUESA , M. GOICOECHEA"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699504029661?idApp=UINPBA000064"
    "url" => "/02116995/00000024000000S1/v0_201502091335/X0211699504029661/v0_201502091335/es/main.assets"
  ]
  "itemAnterior" => array:15 [
    "pii" => "X0211699504029688"
    "issn" => "02116995"
    "estado" => "S300"
    "fechaPublicacion" => "2004-02-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2004;24 Supl 1:27"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 2029
      "formatos" => array:3 [
        "EPUB" => 225
        "HTML" => 1376
        "PDF" => 428
      ]
    ]
    "en" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "Efecto del bloqueo del sistema renina angiotensina sobre la progresión de la nefropatía diabética"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:1 [
          "paginaInicial" => "27"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "S. SHAHINFAR"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "S. SHAHINFAR"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699504029688?idApp=UINPBA000064"
    "url" => "/02116995/00000024000000S1/v0_201502091335/X0211699504029688/v0_201502091335/en/main.assets"
  ]
  "en" => array:8 [
    "idiomaDefecto" => true
    "titulo" => "Progresión del sistema renina angiotensina, remisión y regresión de las nefropatías crónicas"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:1 [
        "paginaInicial" => "28"
      ]
    ]
    "autores" => array:1 [
      0 => array:2 [
        "autoresLista" => "G. REMUZZI"
        "autores" => array:1 [
          0 => array:1 [
            "nombre" => "G. REMUZZI"
          ]
        ]
      ]
    ]
    "textoCompleto" => "NEFROLOGÍA. Vol. XXIV. Número Extraordinario (I). 2004 Progresión del sistema renina angiotensina, remisión y regresión de las nefropatías crónicas G. Remuzzi, M.D. FRCP. Negri Bergamo Laboratories. Bergamo. Italy. The number of patients with chronic renal disease is increasing world-wide. Most of chronic nephropathies lack of a specific treatment and progress relentlessly toward ESRD. In the last two decades an enormous wealth of information have been gathered from animal and human studies that have shed light on the mechanisms of progression and indicated means to prevent it. The concept of renoprotection has emerged and is already growing into a combined approach to renal diseases. Pharmacological control of blood pressure and reduction of proteinuria have proven to be the most important measures to arrest progression. A multimodal protocol is emerging as the modern management for renal patients, which includes combination of several antihypertensive drugs lowering lipids, smoking cessation, tight glucose control for diabetics. A number of new compounds are under evaluation in animal studies, and hopefully will become soon part of the treatment strategy. With the available therapies, delay of dialysis initiation is an achievable goal today for many patients with chronic nephropathies, but it is only a limited result, being the perspective of less dialysis what is really needed. Remission of renal diseases and regression of renal structural damage of the kidney are the pre-requisite for such objective: there are initial experimental and clinical data that give support to the notion that it is possible. Less dialysis (and maybe no more, for some patients) remains an optimistic but not unfounded perspective for the years to come. Renal replacement therapy (RRT), either by hemodialysis, peritoneal dialysis, or renal transplantation, provides patients with end stage renal disease (ESRD) with a long survival, and in most cases with a good quality of life. In all rich countries every year new dialysis patients outnumber those who died, allowing the stock of patients on RRT to grow in parallel with costs. Providing adequate treatment to all patients is indeed extolling a significant proportion of the health care budget and is being considered with concern by those who have responsibility such as health providers and policy makers. Since the prospect of rationing dialysis and establishing priorities for treatment is out of question, we should take upon us the challenge to search strategies to prevent dialysis for as many patients as possible. Many years ago a Professor of Medicine in Manchester, Dr. Robert Platt, was the first to have the intuition that renal failure was the consequence of structural and functional adaptation to loss of kidney substance. He established the concept of renal failure «as an extremely efficient function by a renal remnant now too small for its task». For many years the nephrologists have spent all the efforts to avoid loss of nephrons, most often with little success, by attempting to cure renal diseases. In the early Eighties Dr. Barry Brenner changed completely the perspective, rather pointing the attention on the preservation of the function of remaining nephrons by blocking the progression due to nephron loss. A completely new era of Nephrology started from his seminal work. 28 "
    "pdfFichero" => "P7-E232-S132-A2978.pdf"
    "tienePdf" => true
  ]
  "idiomaDefecto" => "en"
  "url" => "/02116995/00000024000000S1/v0_201502091335/X021169950402967X/v0_201502091335/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "35393"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Artículos Originales"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/02116995/00000024000000S1/v0_201502091335/X021169950402967X/v0_201502091335/en/P7-E232-S132-A2978.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X021169950402967X?idApp=UINPBA000064"
]
Información del artículo
ISSN: 02116995
Idioma original: Inglés
Datos actualizados diariamente
año/Mes Html Pdf Total
2024 Noviembre 2 8 10
2024 Octubre 40 41 81
2024 Septiembre 46 28 74
2024 Agosto 34 50 84
2024 Julio 31 26 57
2024 Junio 40 33 73
2024 Mayo 46 29 75
2024 Abril 64 36 100
2024 Marzo 33 25 58
2024 Febrero 39 35 74
2024 Enero 38 32 70
2023 Diciembre 33 21 54
2023 Noviembre 38 30 68
2023 Octubre 20 29 49
2023 Septiembre 24 24 48
2023 Agosto 36 25 61
2023 Julio 28 26 54
2023 Junio 33 21 54
2023 Mayo 42 29 71
2023 Abril 27 16 43
2023 Marzo 24 22 46
2023 Febrero 28 17 45
2023 Enero 30 26 56
2022 Diciembre 38 40 78
2022 Noviembre 26 26 52
2022 Octubre 38 44 82
2022 Septiembre 37 31 68
2022 Agosto 32 39 71
2022 Julio 30 55 85
2022 Junio 26 27 53
2022 Mayo 30 37 67
2022 Abril 46 43 89
2022 Marzo 44 35 79
2022 Febrero 30 30 60
2022 Enero 20 39 59
2021 Diciembre 34 40 74
2021 Noviembre 24 31 55
2021 Octubre 31 44 75
2021 Septiembre 37 35 72
2021 Agosto 26 42 68
2021 Julio 25 36 61
2021 Junio 14 21 35
2021 Mayo 23 33 56
2021 Abril 35 74 109
2021 Marzo 30 33 63
2021 Febrero 23 16 39
2021 Enero 23 17 40
2020 Diciembre 13 12 25
2020 Noviembre 16 5 21
2020 Octubre 12 14 26
2020 Septiembre 8 8 16
2020 Agosto 28 11 39
2020 Julio 12 17 29
2020 Junio 23 17 40
2020 Mayo 19 19 38
2020 Abril 24 16 40
2020 Marzo 20 12 32
2020 Febrero 27 13 40
2020 Enero 31 17 48
2019 Diciembre 20 25 45
2019 Noviembre 26 13 39
2019 Octubre 12 8 20
2019 Septiembre 18 20 38
2019 Agosto 15 13 28
2019 Julio 21 25 46
2019 Junio 30 10 40
2019 Mayo 13 20 33
2019 Abril 32 28 60
2019 Marzo 17 17 34
2019 Febrero 13 12 25
2019 Enero 19 14 33
2018 Diciembre 30 23 53
2018 Noviembre 49 10 59
2018 Octubre 37 9 46
2018 Septiembre 32 10 42
2018 Agosto 15 8 23
2018 Julio 23 12 35
2018 Junio 15 10 25
2018 Mayo 16 9 25
2018 Abril 19 8 27
2018 Marzo 17 6 23
2018 Febrero 18 4 22
2018 Enero 16 5 21
2017 Diciembre 26 5 31
2017 Noviembre 10 6 16
2017 Octubre 18 5 23
2017 Septiembre 8 5 13
2017 Agosto 13 2 15
2017 Julio 15 6 21
2017 Junio 12 12 24
2017 Mayo 8 1 9
2017 Abril 11 2 13
2017 Marzo 11 3 14
2017 Febrero 11 1 12
2017 Enero 11 4 15
2016 Diciembre 6 2 8
2016 Noviembre 18 4 22
2016 Octubre 28 8 36
2016 Septiembre 28 3 31
2016 Agosto 39 2 41
2016 Julio 78 8 86
2016 Junio 52 0 52
2016 Mayo 90 0 90
2016 Abril 25 0 25
2016 Marzo 24 0 24
2016 Febrero 39 0 39
2016 Enero 29 0 29
2015 Diciembre 61 0 61
2015 Noviembre 32 0 32
2015 Octubre 30 0 30
2015 Septiembre 29 0 29
2015 Agosto 42 0 42
2015 Julio 24 0 24
2015 Junio 22 0 22
2015 Mayo 19 0 19
2015 Abril 8 0 8
Mostrar todo

Siga este enlace para acceder al texto completo del artículo

Idiomas
Nefrología
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?